Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice

Journal of Lipid Research

Volumn 52, Issue 9, 2011, Pages 1626-1635

  Subramanian, Savitha ^a,b   Goodspeed, Leela ^a,b   Wang, Shari ^a,b   Kim, Jinkyu ^b   Zeng, Lixia ^c   Ioannou, George N ^a   Haigh, W Geoffrey ^a   Yeh, Matthew M ^a   Kowdley, Kris V ^a   O'Brien, Kevin D ^b   Pennathur, Subramaniam ^c   Chait, Alan ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Fatty liver; Low density lipoprotein; Metabolic syndrome; Oxidative stress; Oxidized fatty acids; Oxysterols

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARBOHYDRATE DIET; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE EXACERBATION; DYSLIPIDEMIA; HISTOPATHOLOGY; HYPERINSULINEMIA; INFLAMMATORY CELL; INSULIN RESISTANCE; LIPID DIET; LIPID LIVER LEVEL; LIVER FIBROSIS; MACROPHAGE; MALE; METABOLIC SYNDROME X; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CHOLESTEROL, DIETARY; DIET; DISEASE PROGRESSION; FATTY LIVER; HUMANS; INFLAMMATION; LIVER; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, OBESE; OBESITY; OXIDATIVE STRESS; RECEPTORS, LDL;

EID: 80051826073     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M016246     Document Type: Article

References (49)

1. Marchesini, G., S. Moscatiello, S. Di Domizio, and G. Forlani. 2008. Obesity-associated liver disease. J. Clin. Endocrinol. Metab. 93: S74-S80.
2. Farrell, G C, and C Z Larter. 2006. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology. 43: S99-S112.
3. Marchesini, G., M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, M. Lenzi, A J McCullough, S. Natale, G. Forlani, and N. Melchionda. 2001. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes. 50: 1844-1850. (Pubitemid 33641605)
4. Larter, C Z, and M M Yeh. 2008. Animal models of NASH: Getting both pathology and metabolic context right. J. Gastroenterol. Hepatol. 23: 1635-1648.
5. Browning, J D, and J D Horton. 2004. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 114: 147-152. (Pubitemid 39071617)
6. Shiri-Sverdlov, R., K. Wouters, P J Van Gorp, M J Gijbels, B. Noel, L. Buffat, B. Staels, N. Maeda, M. Van Bilsen, and M H Hofker. 2006. Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates. J. Hepatol. 44: 732-741.
7. Schattenberg, J M, and P R Galle. 2010. Animal models of non-alcoholic steatohepatitis: Of mice and man. Dig. Dis. 28: 247-254.
8. Basciano, H., A E Miller, M. Naples, C. Baker, R. Kohen, E. Xu, Q. Su, E M Allister, M B Wheeler, and K. Adeli. 2009. Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis. Am. J. Physiol. Endocrinol. Metab. 297: E462-E473.
9. Subramanian, S., C Y Han, T. Chiba, T S McMillen, S A Wang, A. Haw 3rd, E A Kirk, K D O'Brien, and A. Chait. 2008. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 28: 685-691. (Pubitemid 351651333)
10. Wouters, K., P J Van Gorp, V. Bieghs, M J Gijbels, H. Duimel, D. Lutjohann, A. Kerksiek, R. Van Kruchten, N. Maeda, B. Staels, et al. 2008. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology. 48: 474-486.
11. Kainuma, M., M. Fujimoto, N. Sekiya, K. Tsuneyama, C. Cheng, Y. Takano, K. Terasawa, and Y. Shimada. 2006. Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis. J. Gastroenterol. 41: 971-980. (Pubitemid 44741410)
12. Matsuzawa, N., T. Takamura, S. Kurita, H. Misu, T. Ota, H. Ando, M. Yokoyama, M. Honda, Y. Zen, Y. Nakanuma, et al. 2007. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology. 46: 1392-1403. (Pubitemid 350155521)
13. Schreyer, S A, C. Vick, T C Lystig, P. Mystkowski, and R C LeBoeuf. 2002. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am. J. Physiol. Endocrinol. Metab. 282: E207-E214.
14. Folch, J., M. Lees, and G H Sloane Stanley. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226: 497-509.
15. Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95: 351-358. (Pubitemid 9194347)
16. Kleiner, D E, E M Brunt, M. Van Natta, C. Behling, M J Contos, O W Cummings, L D Ferrell, Y C Liu, M S Torbenson, A. Unalp-Arida, et al. 2005. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 41: 1313-1321. (Pubitemid 40770284)
17. Chait, A., C Y Han, J F Oram, and J W Heinecke. 2005. Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteinsMarkers or mediators of cardiovascular disease? J. Lipid Res. 46: 389-403.
18. Uhlar, C M, and A S Whitehead. 1999. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265: 501-523. (Pubitemid 29488982)
19. Greco, D., A. Kotronen, J. Westerbacka, O. Puig, P. Arkkila, T. Kiviluoto, S. Laitinen, M. Kolak, R M Fisher, A. Hamsten, et al. 2008. Gene expression in human NAFLD. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G1281-G1287.
20. Koonen, D P, R L Jacobs, M. Febbraio, M E Young, C L Soltys, H. Ong, D E Vance, and J R Dyck. 2007. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes. 56: 2863-2871. (Pubitemid 350223619)
21. Reddy, J K, and M S Rao. 2006. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G852-G858.
22. Seki, S., T. Kitada, T. Yamada, H. Sakaguchi, K. Nakatani, and K. Wakasa. 2002. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J. Hepatol. 37: 56-62. (Pubitemid 34713055)
23. Yang, S., H. Zhu, Y. Li, H. Lin, K. Gabrielson, M A Trush, and A M Diehl. 2000. Mitochondrial adaptations to obesity-related oxidant stress. Arch. Biochem. Biophys. 378: 259-268. (Pubitemid 30397626)
24. Yoshida, Y., M. Hayakawa, and E. Niki. 2005. Total hydroxyoctadecadienoic acid as a marker for lipid peroxidation in vivo. Biofactors. 24: 7-15. (Pubitemid 41750523)
25. Rinella, M E, and R M Green. 2004. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J. Hepatol. 40: 47-51. (Pubitemid 38064712)
26. Gupte, A A, J Z Liu, Y. Ren, L J Minze, J R Wiles, A R Collins, C J Lyon, D. Pratico, M J Finegold, S T Wong, et al. 2010. Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice. Hepatology. 52: 2001-2011.
27. Weisberg, S P, D. McCann, M. Desai, M. Rosenbaum, R L Leibel, and A W Ferrante, Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112: 1796-1808. (Pubitemid 38063703)
28. Xu, H., G T Barnes, Q. Yang, G. Tan, D. Yang, C J Chou, J. Sole, A. Nichols, J S Ross, L A Tartaglia, et al. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112: 1821-1830. (Pubitemid 38063705)
29. Kassel, K M, G L Guo, O. Tawfik, and J P Luyendyk. Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet. Lab Invest. 90: 1794-1804.
30. Day, C P, and O F James. 1998. Steatohepatitis: A tale of two "hits"? Gastroenterology. 114: 842-845.
31. Choi, S S, and A M Diehl. 2008. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. Curr. Opin. Lipidol. 19: 295-300. (Pubitemid 351653569)
32. Nehra, V., P. Angulo, A L Buchman, and K D Lindor. 2001. Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig. Dis. Sci. 46: 2347-2352. (Pubitemid 33042332)
33. Xu, Z J, J G Fan, X D Ding, L. Qiao, and G L Wang. 2010. Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats. Dig. Dis. Sci. 55: 931-940.
34. Kleemann, R., L. Verschuren, M J Van Erk, Y. Nikolsky, N H Cnubben, E R Verheij, A K Smilde, H F Hendriks, S. Zadelaar, G J Smith, et al. 2007. Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: A combined transcriptomics and metabolomics analysis. Genome Biol. 8: R200.
35. Vergnes, L., J. Phan, M. Strauss, S. Tafuri, and K. Reue. 2003. Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J. Biol. Chem. 278: 42774-42784. (Pubitemid 37345887)
36. Mari, M., F. Caballero, A. Colell, A. Morales, J. Caballeria, A. Fernandez, C. Enrich, J C Fernandez-Checa, and C. Garcia-Ruiz. 2006. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab. 4: 185-198. (Pubitemid 44307975)
37. Feng, B., P M Yao, Y. Li, C M Devlin, D. Zhang, H P Harding, M. Sweeney, J X Rong, G. Kuriakose, E A Fisher, et al. 2003. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat. Cell Biol. 5: 781-792. (Pubitemid 37087166)
38. Malhi, H, and G J Gores. 2008. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin. Liver Dis. 28: 360-369.
39. Feldstein, A E, A. Canbay, P. Angulo, M. Taniai, L J Burgart, K D Lindor, and G J Gores. 2003. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology. 125: 437-443. (Pubitemid 36929425)
40. Malhi, H., S F Bronk, N W Werneburg, and G J Gores. 2006. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J. Biol. Chem. 281: 12093-12101. (Pubitemid 43855473)
41. Oliveira, C P, L C da Costa Gayotto, C. Tatai, B I Della Bina, M. Janiszewski, E S Lima, D S Abdalla, F P Lopasso, F R Laurindo, and A A Laudanna. 2002. Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. J. Cell. Mol. Med. 6: 399-406. (Pubitemid 44133960)
42. Roskams, T., S Q Yang, A. Koteish, A. Durnez, R. DeVos, X. Huang, R. Achten, C. Verslype, and A M Diehl. 2003. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am. J. Pathol. 163: 1301-1311. (Pubitemid 37175079)
43. Videla, L A, R. Rodrigo, J. Araya, and J. Poniachik. 2004. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. Free Radic. Biol. Med. 37: 1499-1507.
44. Feldstein, A E, R. Lopez, T A Tamimi, L. Yerian, Y M Chung, M. Berk, R. Zhang, T M McIntyre, and S L Hazen. 2010. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J. Lipid Res. 51: 3046-3054.
45. Hampel, J K, L M Brownrigg, D. Vignarajah, K D Croft, A M Dharmarajan, J M Bentel, I B Puddey, and B B Yeap. 2006. Differential modulation of cell cycle, apoptosis and PPARgamma2 gene expression by PPARgamma agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells. Prostaglandins Leukot. Essent. Fatty Acids. 74: 283-293.
46. Addis, P B 1986. Occurrence of lipid oxidation products in foods. Food Chem. Toxicol. 24: 1021-1030. (Pubitemid 17205303)
47. Brown, A J, and W. Jessup. 2009. Oxysterols: Sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis. Mol. Aspects Med. 30: 111-122.
48. Shibata, N, and C K Glass. 2010. Macrophages, oxysterols and atherosclerosis. Circ. J. 74: 2045-2051.
49. Ferre, N., M. Martinez-Clemente, M. Lopez-Parra, A. Gonzalez-Periz, R. Horrillo, A. Planaguma, J. Camps, J. Joven, A. Tres, F. Guardiola, et al. 2009. Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: Potential involvement of oxysterols. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G553-G562.